Association of serum HMGB2 level with MACE at 1 mo of myocardial infarction: Aggravation of myocardial ischemic injury in rats by HMGB2 via ROS
Zhu Hui Liu, Dao Peng Dai, Feng Hua Ding, Wen Qi Pan, Yue Hua Fang, Qi Zhang, Man Li, Ping Yang, Xiao Qun Wang, Ying Shen, Ling Jie Wang, Xiao Xiang Yan, Yu Hu He, Ke Yang, Rui Yan Zhang, Wei Feng Shen, Ying Chen, Lin LuAmerican Journal of Physiology - Heart and Circulatory Physiology2017
High-mobility group box (HMGB) family is related to inflammatory diseases. We investigated whether serum HMGB2 levels are related to myocardial infarction (MI) severity and major adverse cardiac events (MACE) during MI. We included 432 consecutive patients with ST-segment elevation myocardial infarction and 312 controls. Serum HMGB2 levels were significantly higher in MI patients than in controls. Increased HMGB2 levels were associated with MACE and negatively with ejection fraction in MI patients. HMGB2 was an independent determinant of MACE in logistic regression analysis. HMGB2 protein (10 ?g) or saline was injected intramyocardially in MI rats, with or without coadministration of the NADPH oxidase inhibitor apocynin. After 72 h, pathological, echocardiographic, and hemodynamic examina- tions showed that HMGB2 increased infarct size and worsened cardiac function in MI rats. Moreover, HMGB2 administration en- hanced reactive oxygen species (ROS) production, cell apoptosis, inflammation, and autophagosome clearance impairment, which were attenuated by coadministration of apocynin or knock down of receptor for advanced glycation end products (RAGE). In conclusion, increased serum HMGB2 levels are associated with MI severity and MACE at 1 mo. HMGB2 promotes myocardial ischemic injury in rats and hypoxic H9C2 cell damage via ROS provoked by RAGE.